Pdt Partners, LLC G1 Therapeutics, Inc. Transaction History

Pdt Partners, LLC

$1.01 Billion
Q1 2024

A detailed history of Pdt Partners, LLC transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 22,387 shares of GTHX stock, worth $51,042. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,387

Holding current value

$51,042

% of portfolio

0.01%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $47,012 - $108,129	22,387 New	22,387 $96,000
Q3 2022 Nov 14, 2022	SELL	$5.17 - $16.99 $175,428 - $576,504	-33,932 Reduced 42.66%	45,605 $570,000
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $321,329 - $676,859	79,537 New	79,537 $393,000
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $672,397 - $1.15 Million	-51,094 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$19.57 - $26.32 $808,475 - $1.09 Million	-41,312 Reduced 44.71%	51,094 $1.12 Million

Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $111,088 - $205,936	-6,319 Reduced 6.4%	92,406 $2.22 Million
Q4 2020 Feb 16, 2021	SELL	$10.99 - $20.4 $452,777 - $840,459	-41,199 Reduced 29.44%	98,725 $1.78 Million
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $1.14 Million - $2.35 Million	99,005 Added 241.95%	139,924 $1.62 Million
Q2 2020 Aug 14, 2020	BUY	$9.57 - $24.37 $391,594 - $997,196	40,919 New	40,919 $993,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

14.7M

Call Options Held

631K

Put Options Held

347K

Vanguard Group Inc Valley Forge, PA

2.08M
Shares

$4.75 Million
0.0% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

951K
Shares

$2.17 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

904K
Shares

$2.06 Million
0.01% of portfolio
Raymond James & Associates St Petersburg, FL

803K
Shares

$1.83 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

785K
Shares

$1.79 Million
0.0% of portfolio

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $97.5M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account